Skip to main content

Posts

Showing posts from August, 2023

AI Safety 2026: The New Pharma Standard

AI Safety 2026: The New Pharma Standard - Regulated AI & Model Drift Monitoring AI Safety 2026: The New Pharma Standard - A comprehensive guide to regulated AI systems, model drift monitoring, and pharmaceutical compliance The pharmaceutical and medical device industries have officially moved past the "experimentation phase" of Artificial Intelligence. In boardrooms from Basel to Boston, the conversation has shifted from "Can AI help us?" to the more pressing question: "Is our AI safe, regulated, and ready for a clinical audit?" By end of 2025, the FDA had approved or cleared 1,016 medical devices using AI/ML technologies- nearly double the number from 2022. Yet regulatory scrutiny has intensified proportionally. The FDA and EMA jointly issued guiding principles in early 2026 establishing that AI governance in drug safety must be explainable, traceable, and inspection-ready -  no different from any other GxP-regulated system. This deep dive...
Post a Comment
Read this Article »

Emerging Trends in Digital Health through Wearables and IoT Devices

Revolutionizing Healthcare:   Exploring Emerging Trends in Digital Health through Wearables and IoT Devices
Post a Comment
Read this Article »

Solubility Formulas, Solubility Charts, and Drug Delivery

The Science Behind Solubility: Solubility Formula, Solubility Chart, and Drug Delivery system In the intricate world of pharmaceuticals, understanding solubility is crucial for effective drug development and delivery. Solubility, the ability of a substance to dissolve in a solvent, plays a pivotal role in determining a drug's bioavailability, efficacy, and even its safety profile.  In this article, we will delve into the science behind solubility, exploring solubility formulas, solubility charts, and their significance in drug delivery. The Basics of Solubility: Solubility forms the foundation of drug formulation. It is governed by various factors, including the drug's molecular structure, the solvent's properties, and temperature. When a drug's solubility is low, its absorption into the bloodstream can be compromised, resulting in suboptimal therapeutic effects. To overcome this, scientists employ solubility-enhancing techniques, making solubility formulas and charts i...
Post a Comment
Read this Article »

Demystifying AI in Drug Discovery: Transforming Pharma R&D

Demystifying AI in Drug Discovery: Transforming Pharma R&D Artificial Intelligence (AI) has swiftly transformed industries, and drug discovery is no exception.  The pharmaceutical research and development (R&D) process has traditionally been lengthy, resource-intensive, and marked by high failure rates. However, with the advent of AI, a new era has dawned, promising to revolutionize the drug discovery landscape.  This article delves into the nuances of AI in drug discovery , exploring how it's reshaping pharma R&D processes and accelerating the journey toward innovative therapies. 1. Understanding AI in Drug Discovery: AI refers to the simulation of human intelligence in machines, enabling them to perform tasks that typically require human cognition, such as learning, reasoning, and problem-solving.  In drug discovery, AI algorithms analyze vast datasets to identify patterns, predict outcomes, and generate insights that aid in the identification and developmen...
Post a Comment
Read this Article »